Table 3 Reduction of mean diastolic blood pressure values at 6 and 12 weeks for each dose of olmesartan and amlodipine FDC
From: Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)
Olmesartan and amlodipine doses | Baseline (mean ± SD) | 6 weeks (mean ± SD) | Difference initial/6 weeks (mean ± SD) | p | 12 weeks (mean ± SD) | Difference initial/12 weeks (mean ± SD) | p |
|---|---|---|---|---|---|---|---|
20/5 mg (N = 183 patients) | 93.44 ± 10.20 | 84.76 ± 7.79 | 8.79 ± 12.85 | <0.001 | 79.24 ± 7.89 | 14.19 ± 12.89 | <0.001 |
40/5 mg (N = 198 patients) | 96.91 ± 7.98 | 86.68 ± 8.72 | 10.03 ± 10.67 | <0.001 | 80.66 ± 6.67 | 16.25 ± 10.87 | <0.001 |
40/10 mg (N = 47 patients) | 103.26 ± 7.77 | 83.59 ± 8.22 | 20.09 ± 12.44 | <0.001 | 78.43 ± 6.07 | 24.83 ± 10.41 | <0.001 |